
Syneos Health®: A unique, fully integrated contract research organization for clinical and commercial solutions.
Founded through the merger of INC Research and inVentiv Health, Syneos Health® is a unique, fully integrated contract research organization (CRO) that provides end-to-end clinical and commercial solutions. The company's core mission is to accelerate the delivery of biopharmaceutical therapies to market, improving patient outcomes globally. Syneos Health offers a comprehensive range of services, including clinical development, bioanalytical services, and commercialization strategies, focusing on the biopharmaceutical and healthcare sectors.
Notable affiliated individuals include industry leaders from both legacy companies, contributing extensive expertise in clinical trials and commercial strategies. Syneos Health has garnered significant investment from prominent venture capital firms and institutional investors. Key achievements include successful partnerships with leading biopharmaceutical companies and a robust portfolio of completed clinical trials. The overall impact of Syneos Health is evident in its ability to streamline the drug development process, ultimately enhancing the availability of innovative therapies for patients worldwide.

Quintiles
quintiles.com

Syapse

IQVIA
iqvia.com

Medpace
medpace.com

ObjectiveHealth
objective.health

Novartis
novartis.com

Vial
vialtrials.com

Medable
medable.com

Catalent
catalent.com

Viatris
viatris.com

Roivant Sciences
roivant.com

Medidata Solutions

Clinical Research IO

ClinOne
clinone.com

Charles River Laboratories
criver.com
Companies similar to Syneos Health include Quintiles, Syapse, IQVIA and Medpace.
Syneos Health was founded in 1998.
Syneos Health's headquarters is located in Morrisville, NC, US.
Syneos Health's most recent funding round was for $524.6M (USD) in March 2021.
As of Mar 1, 2021, Syneos Health has raised a total of $999.6M (USD).
Syneos Health has 29,395 employees as of Feb 5, 2024.